Background Drug exposure has been reported in association with Takotsubo syndrome, but the breadth and relative strength of ...
Pharmacovigilance (PV) teams are facing a sustained operational squeeze: rising individual case safety report (ICSR) volumes, more intake channels (call centers, partner portals, patient programs, ...
Oracle's leading safety platform will help Voisin enhance compliance, mitigate risk, and expand global service offerings for its pharmaceutical clients "As a CRO deeply invested in specialized ...
ArisGlobal, an AI-first technology company at the forefront of life sciences and creator of LifeSphere®, has launched XDI, its Data Intelligence Cortex. Introduced at the company's Breakthrough 2026 ...
Indore (Madhya Pradesh): Artificial Intelligence (AI) is emerging as a powerful tool in strengthening pharmacovigilance and improving patient safety, experts said during a Continuing Medical Education ...
Kenyan PhD student Prestone Ochieng Otieno has died in the UK while pursuing nursing studies, leaving colleagues and Kenya’s medical fraternity in mourning.
Meanwhile, the Asia-Pacific region is anticipated to register the fastest growth rate. This trend is attributed to a rapidly ...
India's CDSCO ordered new safety warnings for Doxycycline (CNS issues like anxiety/dizziness) and Carbimazole ...
As CGRP-targeted therapies move into wider use, new data are beginning to clarify their role in special populations, the value of switching agents when one fails, and their long-term vascular safety.
Europe’s medicines regulator confirmed that leukoencephalopathy is a rare but serious side effect of levamisole-containing medicines.
The agreements mark an important step towards reinforcing pharmacovigilance systems, promoting rational use of medicines, and ...
BANGALORE, India , Feb. 17, 2026 /PRNewswire/ -- According to Valuates Reports, The global market for AI in Biotechnology was valued at USD 1033 Million in the year 2024 and is projected to reach a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results